When SSRIs fail: the neuromodulation pathway
Device-based neuromodulation therapies may offer a viable alternative for patients with depression who do not achieve adequate response to SSRIs.

Device-based neuromodulation therapies may offer a viable alternative for patients with depression who do not achieve adequate response to SSRIs.
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Device-based neuromodulation therapies may offer a viable alternative for patients with depression who do not achieve adequate response to SSRIs.
Countable Labs claims that its Countable PCR technology is “at least 10 times” more sensitive than conventional PCR.
Participants at the MedTech Forum in Sweden focused on the EMA’s newly launched innovative device pilot and the EU’s IVDR…
Dr Imogen Kretzschmar, consultant psychiatrist at Mamedica, examines medical cannabis's mental health benefits for patients under specialist supervision.
Coredio’s AI software is used to monitor HF parameters via wearables and standard blood pressure cuffs.
The fireflyGO platform aims to reduce manual steps in sequencing, potentially increasing reproducibility and cutting staffing requirements.
Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.
The Libre Duo systems are the first glucose-ketone monitors to reach the diabetes market.
According to GlobalData, the TAVR market was worth $7.0bn in 2025 and is projected to reach $13.8bn in 2035 at…
The integration will apply to Siemens Healthineers’ 1.5T, 3T, and 0.55T MRI systems, including the MAGNETOM Free.XL.
Learn more about Alleima’s life changing medical-solutions